These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24820676)

  • 1. Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials.
    Villacorta R; Hay JW; Messali A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):545-58. PubMed ID: 24820676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model to Determine the Cost-Effectiveness of Screening Psoriasis Patients for Psoriatic Arthritis.
    Iragorri N; Hazlewood G; Manns B; Bojke L; Spackman E;
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):266-274. PubMed ID: 31733035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures in psoriatic arthritis clinical trials.
    Reddy SM; Bingham III CO
    Curr Rheumatol Rep; 2005 Aug; 7(4):299-305. PubMed ID: 16045833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis assessment tools in clinical trials.
    Mease PJ; Antoni CE; Gladman DD; Taylor WJ
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii49-54. PubMed ID: 15708937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Power of crowdsourcing: novel methods of data collection in psoriasis and psoriatic arthritis.
    Armstrong AW; Harskamp CT; Cheeney S; Wu J; Schupp CW
    J Am Acad Dermatol; 2012 Dec; 67(6):1273-1281.e9. PubMed ID: 22818792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative.
    Perez-Chada LM; Cohen JM; Gottlieb AB; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    Arch Dermatol Res; 2018 Nov; 310(9):701-710. PubMed ID: 30167814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prologue: 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Mease PJ; Gladman DD
    J Rheumatol; 2011 Mar; 38(3):522-5. PubMed ID: 21362779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.
    Lebwohl MG; Bachelez H; Barker J; Girolomoni G; Kavanaugh A; Langley RG; Paul CF; Puig L; Reich K; van de Kerkhof PC
    J Am Acad Dermatol; 2014 May; 70(5):871-81.e1-30. PubMed ID: 24576585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.
    Langham S; Langham J; Goertz HP; Ratcliffe M
    BMC Med Res Methodol; 2011 Mar; 11():32. PubMed ID: 21453459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of disease activity and outcomes in psoriatic arthritis.
    Kavanaugh A; Cassell S
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S142-7. PubMed ID: 16273798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis and psoriatic arthritis overview.
    Menter A
    Am J Manag Care; 2016 Jun; 22(8 Suppl):s216-24. PubMed ID: 27356193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of psoriatic arthritis on patient function and quality of life: lessons learned from other rheumatologic conditions.
    Mease PJ
    Semin Arthritis Rheum; 2009 Feb; 38(4):320-35. PubMed ID: 18304610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psoriasis and psoriatic arthritis--is climate therapy a treatment or a leisure activity?].
    Mørk C; Ozek M; Wahl AK
    Tidsskr Nor Laegeforen; 2004 Jan; 124(1):60-2. PubMed ID: 14716397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.
    Myers WA; Gottlieb AB; Mease P
    Clin Dermatol; 2006; 24(5):438-47. PubMed ID: 16966023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels.
    Bhutani T; Wong JW; Bebo BF; Armstrong AW
    JAMA Dermatol; 2013 Jun; 149(6):717-21. PubMed ID: 23783152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
    Dalal DS; Lin YC; Brennan DM; Borkar N; Korman N; Husni ME
    Semin Arthritis Rheum; 2015 Jun; 44(6):641-5. PubMed ID: 26058346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.